Cite
HARVARD Citation
Zivadinov, R. et al. (2018). No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study. Current medical research and opinion. pp. 1431-1440. [Online].